FcγRIIIa and FcγRIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia (Q44620749)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 16, 2003

edit

Language	Label	Description	Also known as
English	FcγRIIIa and FcγRIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia	scientific article published on October 16, 2003

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

retrieved

4 December 2017

title

Fc gamma RIIIa and Fc gamma RIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

retrieved

4 December 2017

FcγRIIIa and FcγRIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia (English)

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

main subject

lymphocyte

0 references

leukemia

1 reference

based on heuristic

inferred from title

rituximab

1 reference

based on heuristic

inferred from title

cell biology

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

immunology

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

biochemistry

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

author

John C. Byrd

series ordinal

6

object named as

John C Byrd

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

retrieved

4 December 2017

Ian W. Flinn

series ordinal

2

object named as

Ian W. Flinn

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563637

retrieved

22 March 2024

author name string

Rama Modali

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

retrieved

4 December 2017

Donn Young

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

retrieved

4 December 2017

Sherif S. Farag

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563637

retrieved

22 March 2024

Teresa A. Lehman

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563637

retrieved

22 March 2024

language of work or name

English

0 references

publication date

16 October 2003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

retrieved

4 December 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://ashpublications.org/blood/article-pdf/103/4/1472/1694961/zh800404001472.pdf

file format

Portable Document Format

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563637

retrieved

22 March 2024

http://ashpublications.org/blood/article-pdf/103/4/1472/1694961/zh800404001472.pdf

file format

Portable Document Format

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

published in

Blood

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

retrieved

4 December 2017

volume

103

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

retrieved

4 December 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

retrieved

4 December 2017

page(s)

1472-1474

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

retrieved

4 December 2017

cites work

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

series ordinal

1

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

series ordinal

2

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Rituximab dose-escalation trial in chronic lymphocytic leukemia

series ordinal

3

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity

series ordinal

4

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Rituximab (anti-CD20) therapy of B-cell lymphomas: direct complement killing is superior to cellular effector mechanisms

series ordinal

7

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Clustered CD20 induced apoptosis: src-family kinase, the proximal regulator of tyrosine phosphorylation, calcium influx, and caspase 3-dependent apoptosis

series ordinal

9

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin.

series ordinal

10

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

series ordinal

11

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene

series ordinal

12

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease

series ordinal

13

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

IgG Fc receptor polymorphisms in human disease: implications for intravenous immunoglobulin therapy

series ordinal

15

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Chronic lymphocytic leukemia

series ordinal

16

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

series ordinal

17

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Complement-mediated cell death induced by rituximab in B-cell lymphoproliferative disorders is mediated in vitro by a caspase-independent mechanism involving the generation of reactive oxygen species

series ordinal

18

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction

series ordinal

19

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

series ordinal

21

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma

series ordinal

22

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance

series ordinal

23

1 reference

stated in

Crossref

DOI

10.1182/BLOOD-2003-07-2548

reference URL

https://api.crossref.org/works/10.1182/BLOOD-2003-07-2548

retrieved

22 March 2024

Identifiers

DOI

10.1182/BLOOD-2003-07-2548

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

retrieved

4 December 2017

PubMed publication ID

14563637

1 reference

stated in

Europe PubMed Central

PubMed publication ID

14563637

retrieved

4 December 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44620749&oldid=2109411971"